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BACKGROUND: Pediatric frequent emergency department (ED) utilizers contribute a significant 
proportion of ED visits, but no studies specifically address children with cancer. 
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METHODS: A retrospective study of Pediatric Health Information System analyzing ED visits for 
children with cancer, including ED visits within 365 days from the first inpatient encounter with a 
discharge diagnosis code for malignancy. We defined frequent ED utilizers as those with 4 or more 
visits in the year (top 10
th
 percentile). Patient characteristics and ED services (medications, laboratory 
or imaging) for discharged children were assessed. Factors associated with being a frequent ED 
utilizer were examined with multivariable regression.  
 
RESULTS: Frequent utilizers accounted for 58% of ED visits. Frequent utilizers differed from 
infrequent utilizers in terms of type of cancer; 39.3% of frequent utilizers had acute lymphoblastic 
leukemia (ALL) and 16.0% had central nervous system (CNS) tumors compared with infrequent 
utilizers (21.9% had ALL and 24.8% CNS tumors, p-value <0.001). Frequent utilization was 
associated with: age 5-9 years (OR=1.4, 95%CI 1.2-1.6) or 1-4 years (OR=2.1, 95%CI 1.8-2.4) or <1 
year (OR=2.2, 95%CI 1.9-2.6) compared to 15-19 years, Hispanic ethnicity (OR 1.3, 95%CI 1.1-1.5) 
compared to white, non-Hispanics, and urban residence (OR=1.5, 95%CI 1.3-1.7). Few children with 
cancer received no medication, laboratory, or imaging during their ED visit (frequent 11.0% vs 
infrequent 12.5%, p=0.01).  
 
CONCLUSION: The ED is integral to the care provided to children with cancer. The subset of 
frequent utilizers should be the focus of future research and quality improvement efforts.  
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Children with cancer represent a unique population of patients who have the potential to 
experience life-threatening complications of their cancer or associated therapy.[1-4] The ability to 
receive urgent evaluation and management is likely integral in the improved survival of this 
population.[5] 
Our previous analysis of a nationally representative emergency department (ED) database, 
Nationwide Emergency Department Sample (NEDS), revealed that there was a large range of reasons 
children with cancer present to the ED.[6] This analysis was limited by the lack of patient specific 
identifiers within the NEDS, which did not allow the determination of the number and frequency of 
ED visits per patient. Previous literature has demonstrated that there are certain populations of 
pediatric patients who utilize the ED to a greater extent than the general population,[7,8] but this has 
not been explored within the pediatric oncology population. 
Frequent use of ED services is defined as recurrent ED use over a period of time by specific 
individuals.[9,10] The rate of repeat visits to the pediatric ED has been proposed as a quality 
improvement metric, with the assumption being that frequent ED utilizers are receiving suboptimal 
healthcare necessitating recurrent ED visits. Pediatric oncology frequent ED utilizers could either 
represent a population where better anticipatory guidance could decrease ED use or this may represent 
a population with acute or time-sensitive healthcare needs such that the ED is an essential aspect of 
their care, in coordination with the oncology team. 
The objectives of this study were to (a) evaluate patient and ED encounter characteristics of 
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Study Design and Setting 
A retrospective cohort study was performed using data from the Pediatric Health Information 
System (PHIS), an administrative and resource utilization database from 45 freestanding children’s 
hospitals. Participating hospitals were located in non-competing markets of 27 states plus the District 
of Columbia and account for ~15% of all pediatric hospitalizations in the United States (U.S.). Data 
for these analyses were extracted between January 1, 2011 and September 30, 2013. Only hospitals 
that submitted ED data to PHIS throughout the study period were included, resulting in data from 39 
hospitals. The PHIS database contains data as follows: patient-level data (demographic characteristics, 
diagnoses, and procedures), and billing data (all medication, diagnostic imaging, laboratory, and 
supply charges to individual patients). All data are de-identified before inclusion into the database; 
however, encrypted medical record numbers allow for continual tracking of individual patients across 
multiple encounters at the same hospital.  The Children’s Hospital Association (Overland Park, KS) 
and participating hospitals monitor the quality and integrity of data jointly, as described 
previously.[11] The data for this analysis was de-identified and therefore was considered exempt from 
institutional review board approval by Indiana University School of Medicine.  
 
Study Population/Identification of Cases 
The cohort of children with cancer was defined based on the identification using the 
International Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) codes for 
malignancy (140.x-209.x, 235.x-239.x). First, we identified the index encounter as the inpatient 
encounter with an ICD-9-CM code for malignancy with no prior cancer hospitalization within the 
prior 365 days. We then analyzed ED visits for each patient over the following one year (365 days) 
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after inpatient discharge from the index encounter. Patients between the ages 0-19 years were 
included in this analysis.  
 
Outcome and Exploratory Variables 
The primary outcome of interest was ED utilization, categorized as frequent vs. infrequent ED 
utilizers. In order to identify frequent ED utilizers, we evaluated the number of ED visits by children 
with cancer and found that the median was 1 (interquartile range 0-2), with the 90
th
 percentile of 4 
visits. The criterion for “frequent ED utilizer” was chosen as the top 10
th
 percentile.  
We assessed the patient factors associated with being a frequent compared to infrequent ED 
utilizer. The following patient characteristics were included: gender, age (<1 year, 1-4 years, 5-9 
years, 10-14 years, 15-19 years – based on clinical differences in development and types of cancers), 
race/ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, Asian, or Other), most common 
types of childhood cancers (acute lymphoblastic leukemia (ALL), acute myelogenous leukemia 
(AML), central nervous system tumors (CNS), solid tumors (non-CNS), Hodgkin lymphoma, and 
non-Hodgkin lymphoma), transplant status flag (defined using Feudtner’s complex chronic condition 
codes, included stem cell transplant),[12] primary payer (Public/governmental, private, other), median 
income quartile per ZIP code, and urban/rural patient residence (based on the Rural Urban 
Commuting Area (RUCA) code of the patient’s home ZIP code).[13] 
 We were interested in quantifying the ED services provided to children with cancer, 
specifically those whose visits that resulted in discharge to home (with no inpatient admission). 
Healthcare services were evaluated for all ED visits that resulted in discharge to home including: 
medication administration (other than acetaminophen or ibuprofen), laboratory testing, or radiologic 
imaging performed.  We further identified visits where antibiotics were administered, either in 
combination with laboratory testing and/or imaging. Medication delivery was determined using the 
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National Drug Code Directory,[14] and laboratory testing or radiologic imaging was determined using 
charges for such services, as had been done previously on general pediatric population.[15]   
 
Statistical Analyses 
We summarized patient and encounter characteristics using frequencies and percentages, and 
compared them across groups (frequent vs. infrequent ED utilizers) using chi-square tests.  
We used multivariable logistic regression to estimate factors associated with frequent ED 
utilization for pediatric patients with cancer while accounting for clustering of patients within 
hospitals through the inclusion of a random hospital intercept. Variables included in our model were 
based on clinical judgment a priori: gender, patient’s age category, dichotomous variables for the 
presence or absence of each of the most common cancer diagnoses, presence of a transplant flag, 
primary expected payer, median income quartile per ZIP code, and urban/rural patient residence. A 
significance level of 0.05 was utilized for all analyses without adjustment for multiple comparisons. 
All analyses were performed using SAS v9.4 (SAS Institute, Cary, NC).  
 
Results 
Characteristic of the study population 
We identified 17,943 children with cancer who received care at 39 children’s hospitals in the 
United States, and followed this cohort for one year to assess ED utilization. Over the one-year time 
span that followed an index inpatient admission, there were 26,770 ED visits. There were 2,631 
frequent ED utilizers who had 4 or greater ED visits within one year (top 10
th
 percentile). Frequent 
ED utilizers accounted for 58% of ED visits.  
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Table I demonstrates the patient level characteristics of children with cancer who presented to 
the ED, stratified by frequent ED utilization status. Children with cancer under the age of 5 years 
represented a larger proportion the frequent ED utilizers (47.6% vs 32.6% among infrequent utilizers, 
p=<0.001). Among the frequent ED utilizers, there were higher proportions of: Hispanic patients 
(23.8% vs 19%, p=<0.001), patients with ALL (39.3% vs 21.9%, p=<0.001) or NHL (6.5% vs 6.0%, 
p=<0.001), public or governmental insurance primary payers (50.1% vs 44.8%, p=<0.001), median 
household income per ZIP codes in the 2
nd
 quartile (24.5% vs 22.1%, p=0.02), and living in an urban 
area (86.6% vs 80.3%, p=<0.001).  
 
Factors associated with frequent ED utilizers among children with cancer 
 In a multivariable analysis (Table II), factors associated with significantly increased odds of 
being a frequent ED utilizer among children with cancer included age category of 5-9 years (OR=1.4, 
95%CI 1.2-1.6) or 1-4 years (OR=2.1, 95%CI 1.8-2.4) or <1 year (OR=2.2, 95%CI 1.9-2.6) compared 
to ages 15-19 years, Hispanic race/ethnicity (OR 1.3, 95%CI 1.1-1.5) compared to white, non-
Hispanics, and living in an urban area (OR=1.5, 95%CI 1.3-1.7) as compared to rural.  
 
Discharge rates among children with cancer 
Overall, 43.9% of children with cancer were discharged home from the ED. Discharge rates differed 
by frequent ED utilizer status (frequent 44.7% versus Infrequent 42.7%, p=<0.001). 
 
Healthcare services for ED encounters that resulted in discharge to home 
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 Of the 11,748 ED encounters that resulted in discharge to home (no inpatient admission), 
11.6% received no medications (other than acetaminophen or ibuprofen), laboratory testing, or 
radiologic imaging (Table III). Among children with cancer, 34.2% of patients discharged from the 
ED received laboratory testing and antibiotic administration. Discharge ED encounters among 
frequent ED utilizers were significantly more likely to have received antibiotics and laboratory testing 
(with or without imaging).  
 
Discussion 
In this study using administrative data from 39 U.S. children’s hospitals, we found that 
frequent ED utilizers (the top 10
th
 percentile by ED visit frequency) accounted for the majority of 
visits (58%). Frequent ED utilizers were more likely to be younger in age (less than 9 years old), of 
Hispanic ethnicity, and have ALL than infrequent utilizers. Few children with cancer (overall 11.6%) 
had an ED visit without associated medication use, laboratory or radiologic testing. This is in contrast 
with a previous study of the general pediatric population that found that 8% of children accounted for 
24% of ED visits in one year and 32% had visits without medication use, laboratory or radiologic 
testing.[15] This study contributes to our understanding of ED utilization by children with cancer by 
demonstrating the characteristics of frequent ED utilizers. The findings from this study may be used 
to identify the children with cancer who are more likely to become frequent ED utilizers, based on 
demographic characteristics available in administrative datasets, in order to perform targeted 
prospective studies aimed at better understanding the patient experience and identifying measures to 
improve their care.  
 The definition of a frequent ED utilizer has varied substantially in the literature, but has 
commonly been defined as at least 4 visits within a one year time frame.[9,16-22] In this study, we 
chose a frequent utilization cutoff based on the distribution of the number of ED visits among children 
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with cancer, which happened to align with at least 4 visits in the year. We revealed that frequent ED 
utilizers among children with cancer (the top 10
th
 percentile) contributed more than half of ED visits. 
Yet, unlike adult ED literature focused on quality improvement to decrease ED usage by frequent 
utilizers whose needs could be served in the primary care setting, we suspect that the ED is an integral 
aspect of care for children with cancer. It is likely that the ED utilization by frequent utilizers with 
cancer is due to increased risk of critical illness and complications of therapy that require emergent 
evaluation, rather than overuse of the ED system unnecessarily. Therefore, we believe that frequent 
ED utilizers need to be further explored in order to evaluate the appropriateness of their ED 
utilization. Specific information that should be collected and incorporated into future analyses 
includes chief complaint for ED visit, current cancer therapy, patient’s comorbid conditions, and 
laboratory data obtained during the ED encounter. This form of comprehensive evaluation of frequent 
ED utilizers could help identify possible targets for interventions that could provide safe alternatives 
to ED visits and subsequent admissions.  
 Younger age and a diagnosis of ALL were important factors associated with increased odds 
of being a frequent ED utilizer. Several explanations could account for these findings. First, younger 
children are developmentally less able to relay their complaints, and therefore caregivers may be more 
likely to seek medical evaluation. Second, the most common childhood malignancy is ALL, which 
has the highest incidence peak at ages 1-4 years.[23] The risk adapted therapies for ALL typically are 
mainly outpatient based therapies that last for 2-3 years, but the most intense phases occur within the 
first year of therapy. Therefore, while children with ALL are exposed to treatment for a longer 
duration of time under which they may require emergent evaluations, the ED needs noted in this study 
may be greater than those after the first year of treatment. This is in comparison to AML therapy that 
is of shorter duration and predominately inpatient based. Unfortunately, our dataset does not include 
information related to disease characteristics (stage or risk stratification) or current phase of treatment. 
Exploring associations between these factors and ED utilization will be key for future investigations.   
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 Socioeconomic factors were significantly associated with meeting criteria for frequent ED 
utilization among children with cancer. Importantly, there were a higher proportion of frequent ED 
utilizers with public insurance and Hispanic ethnicity. Yet, there was no significant association with 
being a frequent ED utilizer for those with Black, non-Hispanic and Other race/ethnicity or among 
those living in ZIP codes with the lowest median household incomes. These findings may be 
representative of patient- or family-specific socioeconomic factors that are not readily available in this 
dataset, but are important factors influencing ED utilization that will need to be explored in further 
detail. Specifically, it will be imperative to incorporate patient travel distance and transportation 
barriers into future evaluations of ED utilization. Furthermore, socioeconomic differences may impact 
parental knowledge or comfort level with outpatient management, thus contributing to increased use 
of the ED among children with cancer. Studies to explore whether language barriers contribute to 
increased use of the ED is a specific area for further investigation, as language barriers can add a layer 
of complexity to phone triaging that may be performed by the oncology team prior to referral to the 
ED.[21,24]  
 This analysis provides a unique perspective of ED care by children with cancer at children’s 
hospitals in the US. In contrast to adult oncology, most children with cancer receive their oncology 
care in urban settings at tertiary care hospitals. Yet, they may live in areas that are geographically 
dispersed throughout an entire state in some regions of the country. A future analysis of the impact of 
distance from the children’s hospital on ED usage and ED disposition is warranted to truly understand 
the complicated interaction between children with cancer and emergency care.  
 Our assessment of the healthcare resources used during the ED encounters for children with 
cancer highlight the high degree of testing and treatment that children with cancer undergo when they 
seek care in the ED. It is possible that the use of laboratory and/or radiology testing is considered a 
necessary part of the evaluation of the patient in order to facilitate decision-making related to ED 
disposition. Specifically, children with cancer who present with fever are treated significantly 
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different depending on the current immunologic function, typically measured through laboratory 
testing to assess the absolute neutrophil count.[25,26] Fevers in children with cancer also represent a 
unique situation where the administration of parental antibiotics aids in the ability to treat the patient 
in the outpatient setting. Conversely, the small proportion of children with cancer that does not require 





 While this study adds insight into characteristics of and ED services received by frequent ED 
utilizers among children with cancer, there are several important limitations. For our analysis, 
children with cancer were captured by identifying the first inpatient encounter with an associated 
ICD-9-CM code for malignancy and then they were followed for 365 days. It is possible that we are 
not accurately capturing all ED usage if the patient was not admitted at the beginning of their 
diagnosis, such as with Hodgkin lymphoma patients who may be diagnosed and started on therapy as 
outpatients. This is likely an underrepresentation of the entirety of ED usage by children with cancer 
because community ED visits are not captured in the PHIS database. Given that data is only collected 
from tertiary care facilities, we are also not able to evaluate if or what care may have been provided to 
the patient prior to their encounter within the PHIS database. Finally, it is important to note that 
diagnoses and procedures for ED and inpatient care are bundled together for those patients who were 
admitted from the ED. Yet, our analysis revealed that frequent ED utilizers among children with 
cancer represent the majority of ED visits with high use of healthcare resources (laboratory testing, 
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In conclusion, frequent ED utilizers (the top 10
th
 percentile) accounted for over half of the ED visits 
by children with cancer. Factors that significantly impacted whether a patient had frequent ED 
utilization at a children’s hospitals included younger age, Hispanic ethnicity, and living in an urban 
area. Only about 1 in 10 children with cancer received no medications (other than acetaminophen or 
ibuprofen), laboratory testing, or radiologic imaging when they sought care in the ED. The ED is an 
integral part of the care provided to children with cancer with high healthcare services used during 
each visit. Future research should be aimed at understanding quality of ED care provided and 
outcomes (both patient-centered and hospital-based) for ED visits among children with cancer. 
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Table I. Patient Level Characteristics of Children with Cancer Presenting to the Emergency Department 











  N (%)  p-value 
Patient Level Characteristics 
Gender 0.03 
    Female 8154 (45.4) 1247 (47.4) 6907 (45.1) 
Age <0.001 
   0-1 year 2425 (13.5) 446 (17.0) 1979 (12.9) 
   2-4 years 3818 (21.3) 804 (30.6) 3014 (19.7) 
   5-9 years 4017 (22.4) 573 (21.8) 3444 (22.5) 
   10-14 years 4057 (22.6) 447 (17.0) 3610 (23.6) 
   15-20 years 3626 (20.2) 361 (13.7) 3265 (21.3) 
Race/Ethnicity <0.001 
   White, Non-Hispanic 9921 (55.3) 1408 (53.5) 8513 (55.6) 
   Black, Non-Hispanic 1754 (9.8) 247 (9.4) 1507 (9.8) 
   Hispanic 3529 (19.7) 625 (23.8) 2904 (19) 
   Asian 580 (3.2) 78 (3) 502 (3.3) 
   Other 2159 (12) 273 (10.4) 1886 (12.3) 
Type of Cancer <0.001 
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   Acute Lymphoblastic Leukemia  4393 (24.5) 1034 (39.3) 3359 (21.9) 
   Acute Myelogenous Leukemia 1191 (6.6) 99 (3.8) 1092 (7.1) 
   Solid Tumor 6302 (35.1) 848 (32.2) 5454 (35.6) 
   Central Nervous System Tumor  4211 (23.5) 421 (16) 3790 (24.8) 
   Hodgkin Lymphoma 748 (4.2) 57 (2.2) 691 (4.5) 
   Non-Hodgkin Lymphoma 1098 (6.1) 172 (6.5) 926 (6.0) 
Transplant <0.001 
    Yes 811 (4.5) 50 (1.9) 761 (5.0) 
Primary Payer <0.001 
   Public/ Governmental 8176 (45.6) 1319 (50.1) 6857 (44.8) 
   Private 8919 (49.7) 1163 (44.2) 7756 (50.7) 
   Other 848 (4.7) 149 (5.7) 699 (4.6) 
Median Household Income per ZIP Code 0.02 
   1
st
 quartile 3695 (21.8) 516 (20.1) 3179 (22.1) 
   2
nd
 quartile 3803 (22.4) 630 (24.5) 3173 (22.1) 
   3
rd
 quartile 4296 (25.4) 647 (25.2) 3649 (25.4) 
   4
th
 quartile 5148 (30.4) 777 (30.2) 4371 (30.4) 
Urban vs Rural Patient Residence  <0.001 
   Urban 14574 (81.2) 2278 (86.6) 12296 (80.3) 
 
Table II. Multivariable Logistic Regression to Evaluate Factors Associated with Frequent 
Emergency Department (ED) Utilizers Among Pediatric Patients with Cancer 
Factors 
Adjusted 
Odds Ratio (OR) 95% CI p-value 
Gender 
  Female 1.1 1.0-1.2 0.047 
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   15-19 years Ref  
   10-14 years 1.1 0.9-1.2 0.42 
   5-9 years 1.4 1.2-1.6 <0.001 
   2-4 years 2.1 1.8-2.4 <0.001 
   0-1 year 2.2 1.9-2.6 <0.001 
Race/Ethnicity    
   White, Non-Hispanic Ref   
   Black, Non-Hispanic 0.9 0.8-1.1 0.52 
   Hispanic 1.3 1.1-1.5 <0.001 
   Asian 1.0 0.8-1.3 0.84 
   Other 1.1 0.9-1.3 0.38 
Type of cancer    
   Acute Lymphoblastic 
Leukemia 
Ref   




   Solid Tumor 0.5 0.5-0.6 <0.001 




   Hodgkin Lymphoma 0.3 0.3-0.5 <0.001 
   Non-Hodgkin Lymphoma 0.7 0.6-0.8 <0.001 
Transplant 
   Yes 0.4 0.3-0.5 <0.001 
Primary Payer 
   Public/ Governmental Ref  
   Private 0.9 0.8-1.0 0.007 
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   Other 1.1 0.8-1.4 0.56 
Median Household Income per ZIP Code 
   4
th
 quartile Ref  
   3
rd
 quartile 0.9 0.8-1.0 0.11 
   2
nd
 quartile 1.0 0.8-1.1 0.61 
   1
st
 quartile 0.8 0.7-1.0 0.02 
Urban vs Rural Patient 
Residence  
   
   Urban 1.5 1.3-1.7 <0.001 
Bolding indicates statistical significance with increased odds of being a frequent ED user 
 
Table III. Services Delivered During the Emergency Department (ED) Encounter with Discharge 









ED visit with discharge to home (n) 11748 6943 4805  
   No Laboratory tests 29.6% 28.3% 31.5% <0.001 
   No Medications* 28.1% 25.7% 31.6% <0.001 
   No Imaging 66.4% 67.2% 65.1% 0.02 
   No Laboratory tests, Medications*,  
   or Imaging 
11.6% 11.0% 12.5% 0.01 
   Received Antibiotics + Laboratory tests 34.2% 35.7% 32.1% <0.001 
   Received Antibiotics + Laboratory tests  
   + Imaging 
9.8% 10.2% 9.1% 0.04 
*other than acetaminophen or ibuprofen 
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